Clinical trial
Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients In Vivo
NCT03037840 is registered in ClinicalTrials.gov with Southern Medical University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients In Vivo
- Lead sponsor
- Southern Medical University, China
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2018
- Completion date
- June 30, 2020
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.